Hospitals & Healthcare News

This section covers the managerial aspects in the Healthcare industry.

U.S. Approves First Drug for Psychosis Linked to Parkinson's

Saturday, April 30, 2016

Acadia Pharmaceuticals Inc39s drug for psychosis linked to Parkinson39s disease was approved in the United States on Friday becoming the first treatment for the condition to get a nod in the country The US Food and Drug Administration however asked Acadia to include a blackbox warning its strictest..

Holography trade body welcomes new UN anti-counterfeiting report

Saturday, April 30, 2016

The trade body for the global hologram industry has welcomed a new United Nations report that reaffirms the technologys important role in anticounterfeiting The UN Interregional Crime and Justice Research Institute UNICRI research report Ensuring Supply Chain Security The Role of AntiCounterfeiting..

AbbVie Agrees to Buy Stemcentrx, Reports Jump in Earnings

Friday, April 29, 2016

Drugmaker AbbVie Inc agreed to acquire a cancerdrug developer Stemcentrx Inc for 58 billion continuing AbbVies aggressive push to build an oncology business With the cashandstock acquisition which includes potential additional payments of up to 4 billion if certain drugdevelopment goals are hit Abb..

Sanofi Launches $9.3 Blillion Fight For U.S. Cancer Firm Medivation

Friday, April 29, 2016

French drugmaker Sanofi went public with a 93 billion offer to buy Medivation on Thursday setting up what could be a lengthy takeover battle after the US cancer firm rebuffed its approaches The decision to target Medivation marks a return to the biotech takeover trail for Sanofi which is looking to..

Acadia Drug Approval Could Clear Way for Axovant Dementia Therapy

Friday, April 29, 2016

An imminent ruling on Acadia Pharmaceuticals Inc39s drug for Parkinson39s disease psychosis is being closely watched by a Bermudabased company with a similar treatment for dementia Axovant Sciences Ltd39s experimental drug for Lewy body dementia after Alzheimer39s the most common form of progressi..

Amgen Profit Rises 17%, Guidance Raised

Friday, April 29, 2016

Amgen Inc said its firstquarter earnings rose 17 on betterthanexpected revenue again boosted by sales of key drugs such as Enbrel and bone drugs Xgeva and Prolia The Thousand Oaks Calif biotechnology company again raised its 2016 outlook Amgen now expects pershare earnings of 1085 to 1120 and reven..

UBS, MPM Team Up on $471 Million Cancer Fund to Speed Drug Development

Thursday, April 28, 2016

A 471 million UBS venture fund aims to generate annual returns north of 10 percent for its European and Asian investors by financing new cancer drugs helping speed them from the lab to the point where drug companies buy their rights Mark Haefele global chief investment officer at the Swiss bank39s ..

Merz Pharma Announces New Investment in Cytrellis Biosystems

Thursday, April 28, 2016

Merz Pharma has made a strategic venture investment in Cytrellis Biosystems a US based company developing a new class of nonsurgical products to combat sagging skin associated with aging Merz has joined a growing set of industry investors to back Bostonbased Cytrellis Biosystems The investment emph..

Montco Pharma firm Partners with Mayo Clinic, National Cancer Institute on Study

Thursday, April 28, 2016

Inovio Pharmaceuticals Inc Is teaming up with the National Cancer Institute and the Mayo Clinic to test its experimental immunotherapy as a potential treatment for hepatitis C The Plymouth Meeting Pa biopharmaceutical company39s new drug candidate called INO8000 will be evaluated in a phaseI clinic..

Bethlehem, PA, Sited For Manufacturing Expansion by Lubrizol Corporation's LifeSciences

Thursday, April 28, 2016

Lubrizol Corporation39s LifeSciences the leading contract development and manufacturing organization for complex drug products is adding commercial drug product manufacturing capacity at its Particle Sciences facility in Bethlehem Pennsylvania The 18000 square foot capacity will include both steril..

AstraZeneca Sells U.S. gout Drug Rights to Ironwood for up to $265 million

Wednesday, April 27, 2016

British drugmaker AstraZeneca Plc said on Tuesday Ironwood Pharmaceuticals Inc IRWDO would buy the US marketing rights for its newly approved gout drug for up to 265 million The deal gives Ironwood the rights to sell the drug Zurampic or lesinurad which was approved in the United States last year t..

Collegium Pharma's opioid painkiller wins U.S. approval

Wednesday, April 27, 2016

Collegium Pharmaceutical Inc said on Tuesday its abusedeterrent painkiller won full marketing approval from US health regulators The drug Xtampza ER won a tentative approval in November but full approval was contingent on the outcome of a lawsuit filed by Purdue Pharma against Collegium Purdue Pha..

Aurobindo Pharma USA, Inc. To Establish National Headquarters In Durham, North Carolina

Wednesday, April 27, 2016

Indiabased Aurobindo Pharma USA Inc will bring 275 new RD and pharmamanufacturing jobs to Durham North Carolina The New Jerseybased maker of generic pharmaceuticals plans to invest over 317 million in a new stateoftheart national headquarters for specialty pharmaceutical RD Aurobindo Pharma USA wil..

Allergan Breaks Ground on $200 Mln Waco Facility Expansion

Tuesday, April 26, 2016

Allergan breaks ground on 200 million waco facility expansion Allergan plc says upon completion waco facility will be capable of producing more than 40 different product formulations Allergan plc says upon completion waco facility will increase its production capacity by more than 50 percent So..

U.S. Panel Finds Sarepta Muscular Dystrophy Drug not Proven Effective

Tuesday, April 26, 2016

An experimental drug to treat Duchenne muscular dystrophy a devastating degenerative disease that mostly affects young boys was not supported by enough evidence to prove it is effective a US advisory panel concluded on Monday decreasing the drug39s chances of approval The vote followed an emotional..

Recursion Pharmaceuticals Announces Research Agreement With Sanofi Genzyme

Tuesday, April 26, 2016

Recursion Pharmaceuticals today announced a research agreement with Sanofi Genzyme the specialty care global business unit of Sanofi to deploy its drug repurposing platform to identify new uses for Sanofis clinical stage molecules across dozens of genetic diseases Recursion generates human cellular..

Fibrocell Receives Orphan Drug Designation for FCX-013

Tuesday, April 26, 2016

Fibrocell Science Inc Sats receives orphan drug designation from the FDA for for FCX013 for the treatment of localized scleroderma Says expect to submit an investigational new drug application for FCX013 to fda in 2017 Source reuterscom ..

Novartis to Prepare the Sale of its Roche Stake

Monday, April 25, 2016

Drugmaker Novartis aims to dispose of a 135 billion Swiss franc 138 billion stake in its local rival Roche ROGS and has already hired banks to support the selling process a Swiss paper reported on Sunday The world39s biggest prescription drugmaker started building up the stake worth 33 percent of ..

Semler gets WHO notice of concern over violation of ideal laboratory and clinical practices

Monday, April 25, 2016

The World Health Organization has alleged fraud and pointed to violations of good laboratory and clinical practices at Semler Research a Bengalurubased contract researcher that was pulled up last week by USFDA on data integrity issues Manipulation of at least five studies over an extended period of..

Lannett to Co-Develop Generic Insulin Product for $21 Billion U.S. Market

Saturday, April 23, 2016

Lannett Company Inc announced plans to codevelop a generic insulin pharmaceutical product for the US market with its strategic partner in China YiChang HEC ChangJiang Pharmaceutical Co Ltd an HEC Group company The product is currently in late stage development Lannett will manage the remaining clini..

TOP